Cerevel Therapeutics Inc... (CERE)
NASDAQ: CERE
· Real-Time Price · USD
44.96
0.33 (0.74%)
At close: Jul 31, 2024, 10:00 PM
Cerevel Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -131.91M | -132.66M | 7.82M | -9.77M | -104.29M | -92.81M | -99.94M | -90.47M | -68.29M | -59.05M | -62.06M | -53.24M | -50.98M |
Depreciation & Amortization | 1.54M | 1.5M | 1.45M | 1.35M | -3.88M | 1.29M | 1.27M | 1.22M | 1.12M | 1.09M | 980K | 601K | 63K |
Stock-Based Compensation | 20.93M | 25.22M | 17.09M | 14.51M | 12.59M | 10.38M | 9.7M | 10.15M | 8.56M | 6.49M | 6.13M | 5.18M | 6.14M |
Other Working Capital | -3.98M | 8.24M | 14.84M | -1.15M | 2.77M | 12.43M | -839K | 20.14M | -2.91M | -1.15M | 3.45M | 1.01M | 4.95M |
Other Non-Cash Items | -5.05M | 27.94M | -7.82M | 9.77M | 3.42M | -13.78M | 5.64M | -2.12M | -3.62M | -5.52M | 5.62M | 776K | -184K |
Deferred Income Tax | n/a | -27.95M | -108.5M | -94.07M | n/a | n/a | n/a | n/a | n/a | n/a | 1.71M | 1.75M | 424K |
Change in Working Capital | -5.18M | 8.52M | 17.33M | 879K | -2.77M | 7.43M | 2.93M | 23.1M | -5.41M | 4.26M | 3.84M | -677K | 8.12M |
Operating Cash Flow | -119.67M | -97.42M | -72.63M | -77.33M | -94.92M | -87.48M | -80.41M | -57.66M | -67.65M | -52.74M | -43.78M | -45.61M | -36.42M |
Capital Expenditures | -271K | -902K | -513K | -2.06M | -336K | -454K | -171K | -1.13M | -2.2M | -1.07M | -1.19M | -3.58M | -4.66M |
Cash Acquisitions | n/a | 149.31K | -51.91K | -63.81K | 38.54M | 26.28K | 387.68K | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -122.65M | -317.06M | -213.09M | -147.49M | -187.63M | -174.49M | -571.68M | -81.32M | -60.24M | -425.16M | n/a | n/a | n/a |
Sales Maturities Of Investments | 142.09M | 167.75M | 265M | 211.3M | 298.75M | 148.21M | 184M | 146.75M | 23.9M | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | -149.31K | 51.91K | 63.81K | -38.54M | -26.28K | -387.68K | 65.43M | -36.34K | -425.16K | n/a | n/a | n/a |
Investing Cash Flow | 19.16M | -150.21M | 51.39M | 61.75M | 110.78M | -26.73M | -387.85M | 64.29M | -38.54M | -426.23M | -1.19M | -3.58M | -4.66M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | -75K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 4.47M | 508.37M | 1.2M | 37.61M | 1.44M | 2.13M | 578.64M | 39.82M | 2.6M | 2.32M | 387.58M | 32.96M | 742K |
Financial Cash Flow | 4.47M | 508.37M | 1.2M | 37.61M | 1.44M | 2.13M | 578.64M | 39.82M | 2.6M | 2.32M | 387.58M | 32.96M | 742K |
Net Cash Flow | -96.03M | 314.08M | -20.04M | 22.04M | 17.3M | -112.08M | 110.38M | 46.45M | -103.59M | -476.66M | 342.62M | -16.23M | -40.34M |
Free Cash Flow | -119.94M | -98.32M | -73.14M | -79.38M | -95.26M | -87.93M | -80.58M | -58.79M | -69.84M | -53.82M | -44.96M | -49.19M | -41.08M |